Study finds high tumour mutation burden predicts immunotherapy response in some, but not all, cancers
A high rate of genetic mutations within a tumour, known as high tumour mutation burden…
Browsing: tumour mutation burden
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Cancer DNA blood tests validated by international research team
- Inflammation a key to targeting pregnancy-associated breast cancer
- First patient-derived organoid model for cervical cancer
- Long-term results from MINDACT trial confirm importance of gene expression signature in choosing breast cancer patients who can be spared chemotherapy
- New CAR T approach minimises resistance, helps avoid relapse in non-Hodgkin’s B-cell lymphoma
- AACR 2021: Novel immunotherapy approach to fight melanoma
- Skin-related side effects: immune therapies
- Activating the brain’s immune system against cancer prevents it from spreading
